Gofen & Glossberg LLC IL boosted its position in Danaher Co. (NYSE:DHR) by 13.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 230,625 shares of the conglomerate’s stock after purchasing an additional 27,554 shares during the period. Gofen & Glossberg LLC IL’s holdings in Danaher were worth $21,407,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. National Asset Management Inc. raised its stake in shares of Danaher by 0.4% during the second quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock valued at $318,000 after acquiring an additional 14 shares in the last quarter. Brighton Jones LLC raised its stake in shares of Danaher by 0.4% during the second quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock valued at $435,000 after acquiring an additional 21 shares in the last quarter. Buckingham Asset Management LLC raised its stake in shares of Danaher by 0.4% during the second quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock valued at $488,000 after acquiring an additional 24 shares in the last quarter. Simmons Bank raised its stake in shares of Danaher by 0.4% during the second quarter. Simmons Bank now owns 7,160 shares of the conglomerate’s stock valued at $604,000 after acquiring an additional 26 shares in the last quarter. Finally, Horizon Investments LLC increased its holdings in Danaher by 0.4% during the second quarter. Horizon Investments LLC now owns 7,828 shares of the conglomerate’s stock valued at $648,000 after buying an additional 28 shares during the period. 76.12% of the stock is owned by institutional investors and hedge funds.
Several equities analysts recently issued reports on the stock. UBS Group assumed coverage on shares of Danaher in a report on Monday. They set a “buy” rating on the stock. Stifel Nicolaus reissued a “buy” rating and set a $110.00 price objective on shares of Danaher in a report on Friday. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a report on Friday, January 12th. Royal Bank of Canada reaffirmed a “hold” rating and issued a $96.00 price target on shares of Danaher in a report on Thursday, January 4th. Finally, Evercore ISI started coverage on shares of Danaher in a report on Wednesday, January 3rd. They issued an “outperform” rating on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Danaher presently has a consensus rating of “Buy” and an average target price of $95.86.
In other Danaher news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the transaction, the chief executive officer now owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. Insiders own 12.20% of the company’s stock.
Danaher Co. (DHR) opened at $99.97 on Tuesday. The stock has a market cap of $69,950.05, a price-to-earnings ratio of 29.49, a P/E/G ratio of 2.18 and a beta of 1.02. Danaher Co. has a 1 year low of $78.97 and a 1 year high of $100.88. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a dividend of $0.14 per share. The ex-dividend date is Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.56%. Danaher’s dividend payout ratio is presently 16.52%.
TRADEMARK VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/01/23/gofen-glossberg-llc-il-has-21-41-million-holdings-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.